SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-045543
Filing Date
2021-04-01
Accepted
2021-04-01 16:02:07
Documents
10
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2111207-1_pre14a.htm PRE 14A 671084
2 GRAPHIC lg_zynerbapharmar-4c.jpg GRAPHIC 72530
3 GRAPHIC sg_armandoanido-bw.jpg GRAPHIC 6657
4 GRAPHIC tm2111207d1-icon_chairfembw.jpg GRAPHIC 877
5 GRAPHIC tm2111207d1-icon_chairperbw.jpg GRAPHIC 840
6 GRAPHIC tm2111207d1-icon_compbw.jpg GRAPHIC 4242
7 GRAPHIC tm2111207d1-icon_mailbw.jpg GRAPHIC 5274
8 GRAPHIC tm2111207d1-icon_memberbw.jpg GRAPHIC 778
9 GRAPHIC tm2111207d1-icon_memfembw.jpg GRAPHIC 871
10 GRAPHIC tm2111207d1-icon_telephobw.jpg GRAPHIC 5694
  Complete submission text file 0001104659-21-045543.txt   807813
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37526 | Film No.: 21797946
SIC: 2834 Pharmaceutical Preparations